SCHEMBL10242828

SCHEMBL10242828

O=C1NCC(c2cccc(C(F)(F)F)c2)N1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2C P28335 4/20 0.48
GUSB P08236 1/20 0.46
HTR1A P08908 1/20 0.46
PBRM1 Q86U86 1/20 0.45
HTR2A P28223 2/20 0.45
HTR2B P41595 2/20 0.45
PARP1 P09874 1/20 0.44
PARP2 Q9UGN5 1/20 0.44
MAPK1 P28482 2/20 0.40
MRGPRX4 Q96LA9 1/20 0.40
KDM4E B2RXH2 1/20 0.40
ALDH1A1 P00352 1/20 0.40
HSD17B10 Q99714 1/20 0.40
MAPT P10636 2/20 0.40
LMNA P02545 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
HTT P42858 1/20 0.40
TSHR P16473 1/20 0.40
KDM1A O60341 1/20 0.39
RCOR1 Q9UKL0 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12696992 0.81 PARP1 (0.58) HTR2CPARP1PARP2ALDH1A1MAPT
SCHEMBL14721701 0.81 PARP1 (0.49) HTR2CGUSBHTR1APBRM1HTR2A
SCHEMBL30640419 0.79 HTR2C (0.51) HTR2CGUSBHTR1APBRM1HTR2A
SCHEMBL3600762 0.79 HTR2C (0.51) HTR2CGUSBHTR1APBRM1HTR2A
SCHEMBL3600768 0.79 HTR2C (0.51) HTR2CGUSBHTR1APBRM1HTR2A
SCHEMBL20956921 0.78 ABCC9 (0.42)
SCHEMBL10244400 0.76 SLC6A3 (0.53) ALDH1A1MAPTHTTTSHR
SCHEMBL3584299 0.75 HTR1A (0.48) HTR2CGUSBHTR1APBRM1HTR2A
SCHEMBL29144910 0.75 HTR1A (0.48) HTR2CGUSBHTR1APBRM1HTR2A
SCHEMBL3584104 0.75 HTR1A (0.48) HTR2CGUSBHTR1APBRM1HTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1765793-B1 ANACETRAPIB AND OTHER CETP INHIBITPRS MERCK SHARP & DOHME (US) 2012-09-26 EP disclosed
EP-2415759-A1 CETP inhibitors Merck Sharp & Dohme Corporation (US) 2012-02-08 EP disclosed